Mardi C. Boer

630 total citations
17 papers, 422 citations indexed

About

Mardi C. Boer is a scholar working on Infectious Diseases, Immunology and Surgery. According to data from OpenAlex, Mardi C. Boer has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Immunology and 4 papers in Surgery. Recurrent topics in Mardi C. Boer's work include SARS-CoV-2 and COVID-19 Research (6 papers), Immune responses and vaccinations (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Mardi C. Boer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Immune responses and vaccinations (5 papers) and Tuberculosis Research and Epidemiology (4 papers). Mardi C. Boer collaborates with scholars based in Netherlands, Italy and United States. Mardi C. Boer's co-authors include Tom H. M. Ottenhoff, Simone A. Joosten, Krista E. van Meijgaarden, Jelle de Wit, Corine Prins, Nynke van Dijk, Jaap T. van Dissel, Jérémy Bastid, Christina Lancioni and Deborah A. Lewinsohn and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Mardi C. Boer

16 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mardi C. Boer Netherlands	11	237	167	94	55	51	17	422
Manuela Zlamy Austria	13	96 0.4×	108 0.6×	130 1.4×	69 1.3×	37 0.7×	30	423
Michael R. D’Agostino Canada	12	258 1.1×	227 1.4×	87 0.9×	120 2.2×	25 0.5×	19	531
John J. Erickson United States	10	282 1.2×	131 0.8×	216 2.3×	52 0.9×	20 0.4×	20	494
Laura Farr United States	8	139 0.6×	194 1.2×	46 0.5×	78 1.4×	130 2.5×	10	470
Nagarjuna R. Cheemarla United States	11	105 0.4×	146 0.9×	161 1.7×	39 0.7×	21 0.4×	18	325
David Eduardo Meza-Sánchez Mexico	12	199 0.8×	238 1.4×	61 0.6×	182 3.3×	27 0.5×	23	525
Megan E. Schmidt United States	7	196 0.8×	233 1.4×	241 2.6×	65 1.2×	28 0.5×	12	496
Marieke van der Heiden Netherlands	11	120 0.5×	77 0.5×	95 1.0×	37 0.7×	17 0.3×	30	335
Camila Matias Peres Brazil	7	109 0.5×	101 0.6×	95 1.0×	64 1.2×	22 0.4×	7	361
Alfred T. Harding United States	9	168 0.7×	117 0.7×	210 2.2×	185 3.4×	17 0.3×	14	522

Countries citing papers authored by Mardi C. Boer

Since Specialization

Citations

This map shows the geographic impact of Mardi C. Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mardi C. Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mardi C. Boer more than expected).

Fields of papers citing papers by Mardi C. Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mardi C. Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mardi C. Boer. The network helps show where Mardi C. Boer may publish in the future.

Co-authorship network of co-authors of Mardi C. Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Mardi C. Boer. A scholar is included among the top collaborators of Mardi C. Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mardi C. Boer. Mardi C. Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ewijk, Catharina E van, Ronald Jacobi, Mirjam J. Knol, et al.. (2024). Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity. Vaccine X. 22. 100593–100593. 1 indexed citations

Brummelman, Jolanda, Nynke Y. Rots, Josine van Beek, et al.. (2024). Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status. Frontiers in Immunology. 15. 1392477–1392477. 2 indexed citations

Verheul, Marije K., Martijn Vos, Alienke J. Wijmenga‐Monsuur, et al.. (2023). Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children. Frontiers in Immunology. 14. 1327875–1327875. 2 indexed citations

Verheul, Marije K., Dirk Eggink, Sophie van Tol, et al.. (2023). Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization. Vaccines. 11(7). 1196–1196. 10 indexed citations

Emmelot, Maarten E., Martijn Vos, Mardi C. Boer, et al.. (2022). SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals. Viruses. 15(1). 101–101. 11 indexed citations

Emmelot, Maarten E., Martijn Vos, Mardi C. Boer, et al.. (2022). Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals. Viruses. 14(7). 1570–1570. 20 indexed citations

Boer, Mardi C., et al.. (2022). The adaptive immune system in early life: The shift makes it count. Frontiers in Immunology. 13. 1031924–1031924. 44 indexed citations

Boer, Mardi C., David Lewinsohn, & Christina Lancioni. (2017). Immunobiology of Pediatric Tuberculosis: Lessons Learned and Implications for an Improved TB-Vaccine. Journal of Pediatric Infectious Diseases. 13(2). 113–121. 1 indexed citations

Park, Byung, et al.. (2016). Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells. The Journal of Immunology. 197(1). 68–77. 26 indexed citations

10.

Boer, Mardi C., Simone A. Joosten, & Tom H. M. Ottenhoff. (2015). Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Frontiers in Immunology. 6. 217–217. 116 indexed citations

11.

Boer, Mardi C., Corine Prins, Krista E. van Meijgaarden, et al.. (2015). Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clinical and Vaccine Immunology. 22(7). 778–788. 46 indexed citations

12.

Boer, Mardi C., Krista E. van Meijgaarden, Delia Goletti, et al.. (2015). KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults. Tuberculosis. 97. 163–171. 26 indexed citations

13.

Boer, Mardi C., Krista E. van Meijgaarden, Simone A. Joosten, & Tom H. M. Ottenhoff. (2014). CD8+ Regulatory T Cells, and Not CD4+ T Cells, Dominate Suppressive Phenotype and Function after In Vitro Live Mycobacterium bovis-BCG Activation of Human Cells. PLoS ONE. 9(4). e94192–e94192. 32 indexed citations

14.

Boer, Mardi C., Krista E. van Meijgaarden, Jérémy Bastid, Tom H. M. Ottenhoff, & Simone A. Joosten. (2013). CD39 is involved in mediating suppression by Mycobacterium bovisBCG‐activated human CD8⁺CD39⁺ regulatory T cells. European Journal of Immunology. 43(7). 1925–1932. 38 indexed citations

15.

Dijk, Nynke van, Mardi C. Boer, Barbara J.M. Mulder, Gert A. van Montfrans, & Wouter Wieling. (2008). Is fatigue in Marfan syndrome related to orthostatic intolerance?. Clinical Autonomic Research. 18(4). 187–93. 22 indexed citations

16.

Dijk, Nynke van, et al.. (2008). Is fatigue in Marfan syndrome related to orthostatic intolerance?. Autonomic Neuroscience. 143(1-2). 3–3.

17.

Dijk, Nynke van, et al.. (2007). Daily, weekly, monthly, and seasonal patterns in the occurrence of vasovagal syncope in an older population. EP Europace. 9(9). 823–828. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact